Manufacturing Site Change Supplements: Content and Submission

FDA Guidance FDA CDRH/CBER 2018-12-01
Home/ Resources/ Manufacturing Site Change Supplements: Content…

Summary

Final Guidance
Manufacturing

This FDA guidance document provides recommendations and regulatory information for the medical device industry. It was issued by the Center for Devices and Radiological Health (CDRH) in collaboration with the Center for Biologics Evaluation and Research (CBER).

Document Details

  • Issuing Authority: FDA CDRH/CBER
  • Status: Final
  • Topic Area: Manufacturing
  • Date: 2018-12-01

Access the Full Document

View on FDA.gov →

Source: U.S. Food and Drug Administration (FDA). This content is provided for informational purposes. Always refer to the official FDA document for the most current version.

Document Details

Document IDFDA-CDRH-MANUFACTURING-SITE-CHANGE-SUPPLEMENTS-CONTENT-AND-
TypeFDA Guidance
AuthorityFDA CDRH/CBER
Publication Date2018-12-01

Download Document

Download PDF

Categories

Quick Info

TypeFDA Guidance
Published ByFDA CDRH/CBER
Date2018-12-01

Regulatory Support

Need help understanding this guidance document?

Contact Us
Scroll to Top